The course will start at 3 pm - Singapore local time (GMT+8)
- To learn about best clinical practice in the management of Non-Small-Cell Lung Cancer (NSCLC) in the adjuvant, locally advanced and metastatic setting
- To understand the importance of pathology and histo-prognostic, molecular factors and liquid biopsies in the management of NSCLC
- To learn about the management of patients after progression, side effects of treatments and the use of targeted agents in NSCLC and obtain some highlights of ongoing clinical research
Download the programme
This course is part of a of a three-steps ESMO global programme on EGFR. The programme is organised into three parts, an education segment (with two educational courses) and a hospital visit segment hosted by partner institutes. Successful applicants will be automatically enrolled (no need to re-submit your application for each component) in the following educational activities:
- ESMO Virtual Preceptorship on NSCLC to be held 6-8 May 2021
- ESMO Virtual Advanced Course on EGFR-mutated NSCLC to be held on 21-23 June 2021
- A 4-days hospital based practical experience in selected
European host institutes (dates for this will be proposed considering both the status of the pandemic and the availability of the host centres. Most likely, it will not be possible to organize site visits until the end of 2021.
It is very important, for the selected participant, to be able to join to all the activities in the programme. Therefore, we kindly ask you to verify your possibility to attend all the events when submitting your application.
How to apply
Application is via online form. During the application process you will be required to upload the following:
Applications for the virtual course are now closed.
Who can apply?
While this course is primarily aimed at oncologists resident in Asia, application is open to all ESMO members.
To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.
Successful applicants will benefit from complimentary registration for this virtual course.
The programme of this virtual event has been accredited with 9 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Pasi A. Jänne, United States
Tony S. K. Mok, Hong Kong
Solange Peters, Switzerland